Strategic Global Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.36M | Sell |
16,958
-25,323
| -60% | -$3.55M | 0.38% | 75 |
|
|
2025
Q4 | $5.19M | Sell |
42,281
-944
| -2% | -$115K | 0.8% | 39 |
|
|
2025
Q3 | $4.8M | Sell |
43,225
-710
| -2% | -$80.7K | 0.73% | 48 |
|
|
2025
Q2 | $4.87M | Buy |
43,935
+2,630
| +6% | +$280K | 0.79% | 43 |
|
|
2025
Q1 | $4.63M | Buy |
41,305
+4,020
| +11% | +$415K | 0.92% | 38 |
|
|
2024
Q4 | $3.44M | Buy |
37,285
+1,490
| +4% | +$134K | 0.63% | 48 |
|
|
2024
Q3 | $3M | Sell |
35,795
-355
| -1% | -$27.1K | 0.59% | 58 |
|
|
2024
Q2 | $2.48M | Buy |
36,150
+689
| +2% | +$46K | 0.52% | 62 |
|
|
2024
Q1 | $2.6M | Sell |
35,461
-1,049
| -3% | -$80.7K | 0.56% | 62 |
|
|
2023
Q4 | $2.96M | Sell |
36,510
-25,408
| -41% | -$1.98M | 0.68% | 51 |
|
|
2023
Q3 | $4.64M | Sell |
61,918
-3,052
| -5% | -$235K | 0.77% | 48 |
|
|
2023
Q2 | $5.01M | Buy |
+64,970
| New | +$5.18M | 0.77% | 49 |
|
|
2020
Q4 | – | Sell |
-41,868
| Closed | -$2.65M | – | 164 |
|
|
2020
Q3 | $2.65M | Buy |
41,868
+3,709
| +10% | +$257K | 0.5% | 65 |
|
|
2020
Q2 | $2.94M | Sell |
38,159
-7,313
| -16% | -$560K | 0.63% | 47 |
|
|
2020
Q1 | $3.4M | Sell |
45,472
-2,007
| -4% | -$139K | 0.87% | 33 |
|
|
2019
Q4 | $3.08M | Sell |
47,479
-2,732
| -5% | -$178K | 0.64% | 45 |
|
|
2019
Q3 | $3.18M | Sell |
50,211
-4,292
| -8% | -$281K | 0.72% | 45 |
|
|
2019
Q2 | $3.68M | Sell |
54,503
-3,232
| -6% | -$213K | 0.78% | 34 |
|
|
2019
Q1 | $3.75M | Buy |
57,735
+22,625
| +64% | +$1.5M | 0.79% | 39 |
|
|
2018
Q4 | $2.2M | Sell |
35,110
-4,790
| -12% | -$335K | 0.78% | 27 |
|
|
2018
Q3 | $3.08M | Sell |
39,900
-127
| -0.3% | -$9.59K | 0.94% | 24 |
|
|
2018
Q2 | $3.02M | Hold |
40,027
| – | – | 0.77% | 32 |
|
|
2018
Q1 | $3.02M | Hold |
40,027
| – | – | 1.03% | 23 |
|
|
2017
Q4 | $2.87M | Sell |
40,027
-1,310
| -3% | -$99.5K | 0.93% | 22 |
|
|
2017
Q3 | $3.35M | Buy |
41,337
+3,063
| +8% | +$234K | 1.28% | 21 |
|
|
2017
Q2 | $2.71M | Sell |
38,274
-4,250
| -10% | -$283K | 1% | 27 |
|
|
2017
Q1 | $2.89M | Sell |
42,524
-3,384
| -7% | -$238K | 1.04% | 25 |
|
|
2016
Q4 | $3.29M | Sell |
45,908
-232
| -0.5% | -$17.2K | 1.22% | 21 |
|
|
2016
Q3 | $3.85M | Hold |
46,140
| – | – | 1.44% | 12 |
|
|
2016
Q2 | $3.85M | Hold |
46,140
| – | – | 1.46% | 12 |
|
|
2016
Q1 | $4.24M | Sell |
46,140
-3,572
| -7% | -$322K | 1.8% | 11 |
|
|
2015
Q4 | $5.03M | Buy |
49,712
+1,671
| +3% | +$174K | 2.14% | 9 |
|
|
2015
Q3 | $4.72M | Buy |
48,041
+29,885
| +165% | +$3.32M | 2.26% | 6 |
|
|
2015
Q2 | $2.13M | Buy |
18,156
+2,740
| +18% | +$299K | 1.24% | 12 |
|
|
2015
Q1 | $1.51M | Buy |
15,416
+2,218
| +17% | +$225K | 1.12% | 17 |
|
|
2014
Q4 | $1.24M | Buy |
+13,198
| New | +$1.36M | 1.11% | 19 |
|
Other funds holding GILD
VCM
VPM
Strategic Global Advisors's GILD Position: Q1 2026 in Review
Strategic Global Advisors reduced its Gilead Sciences (GILD) stake by 60% in Q1 2026, selling an estimated $3.55M and leaving 16,958 shares worth $2.36M. The position accounts for 0.38% of the portfolio, ranked #75.
Strategic Global Advisors first reported a position in GILD in Q4 2014 and has held it in 36 quarters since. The position peaked at $5.19M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Strategic Global Advisors held 16,958 shares of Gilead Sciences worth $2.36M as of Q1 2026.
- Strategic Global Advisors sold 25,323 Gilead Sciences shares in Q1 2026, an estimated $3.55M.
- Gilead Sciences made up 0.38% of Strategic Global Advisors's portfolio in Q1 2026, its #75 holding.
- Strategic Global Advisors first reported a position in Gilead Sciences in Q4 2014 and has held it in 36 quarters since.
- Strategic Global Advisors's Gilead Sciences position peaked at $5.19M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Strategic Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.